Randomized Phase III Trial of Low Molecular Weight Heparin Enoxaparin in Addition to Standard Treatment in Small Cell Lung Cancer: the RASTEN Trial
Annals of Oncology, mdx716, https://doi.org/10.1093/annonc/mdx716 Published: 02 November 2017
Letter to the editor
Nivolumab in non-small cell lung cancer with EGFR mutation Annals of Oncology, mdx745, https://doi.org/10.1093/annonc/mdx745 Published: 17 November 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
Annals of Oncology, mdx707, https://doi.org/10.1093/annonc/mdx707 Published: 13 November 2017
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
Lancet Oncol 2017;Published Online November 9, 2017
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Lancet Oncol 2017;Published Online November 9, 2017 http://dx.doi.org/10.1016/S1470-2045(17)30690-3